Skip to main contentSkip to navigation
Sirius Investors

HBIO Financial Statements & Analysis

Complete financial statements for HBIO including income statement, balance sheet, and cash flow statement. Analyze HBIO's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
-1.2%
Net Income
82.7%
Gross Margin
1.3%
Operating Margin
102.5%

Balance Sheet

Current Ratio
-9.4%
Debt to Equity
36.2%
Asset Turnover
1.5%

Cash Flow

Operating Cash Flow
-54.2%
Net Cash Flow
-65.6%
Free Cash Flow
-69.7%
Cash Flow to Debt
-54.1%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '25TTM Q1 '26ChangeImpact
Revenue86.55M85.53M1.2%
Gross Profit48.75M48.81M0.1%
Operating Income-48.36M1.19M102.5%
Net Income-56.70M-9.78M82.7%
EPS-3.20-0.5582.8%
EBITDA-46.52M-1.87M96.0%
Gross Margin56.32%57.06%1.3%
Operating Margin-55.88%1.39%102.5%
Net Income Margin-65.51%-11.44%82.5%
R&D Expenses8.82M8.83M0.1%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue85.53M86.55M87.37M
Gross Profit48.81M48.75M48.59M
Operating Income1.19M-48.36M-50.28M
Net Income-9.78M-56.70M-53.84M
EPS-0.55-3.20-3.05
EBITDA-1.87M-46.52M-43.82M
Gross Margin57.06%56.32%55.61%
Operating Margin1.39%-55.88%-57.55%
Net Income Margin-11.44%-65.51%-61.62%
R&D Expenses8.83M8.82M8.97M

Our detailed financial analysis helps investors understand HBIO's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track HBIO's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into HBIO's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Harvard Bioscience, Inc. (HBIO) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors